The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
"... Commisioned large scale ..."
Q20: Is Avacta looking to expand its clinical data sets beyond those already announced?
We are carrying out additional validation studies to build larger data sets and strengthen the statistical analysis.
Was going to say "losing money hurts" is only true if you have sold. We have bought into a business, shortly news will arrive and all indications are that this will be extremely positive if so boom through 300p and away. Had to drop before hitting the much discussed highs. But in my opinion these will come. Only thing to do is keep the faith if one bought at recent highs, the research has been done.
I think it was Warren Buffett who likend buying shares to buying a farm. This farm is a gem, virdant acres bursting with potential, a keeper not for selling on. Not at any price, well any price short of 25 pounds a share any hoo.
For what its worth here's my view. I like many bought this share on the back of a detailed analysis. I bought not in the hope of achieving 100% but 10 times that, call me greedy if you like. Covid has served to establish the AffiDX brand and Avacta is at this moment pursuing an addressable market of around 8 billion dollars through discussions with various majors who may adopt Affimers in their tests, nothing to do with Covid. Lets imagine half of those come to fruition, suddently Avacta is earning a conservative 200 million dollars per annum each and every year for the forseeable future. In comparison a one-off Covid (not forgetting all the misery Covid has caused) bonansa is not that significant. I would be happy with 60m this year, a couple of years cash burn. This is but one smallish part of the Avacta story. They can take this to 100p but I wont be selling any this side of 10 pounds and for the most part I will be holding untill 25. Avacta is a major company in the making and shareholders have a chance to be part of the story. No gain without pain as they say. All in my own opinion and not advice but I'm very much on the same page as Al regarding how big this company is going to get. Now you may know of a better investment, but I dont. Just, in the words of the song, "need a little patience" and for your own sanity to stop looking at the share price ever day. Oh one other thing , I dont think its very smart to short this baby. Good luck all.
Sky, for the sake of completeness it should be stated that the Government is led by a buffon and proven liar. He was elected by the Blue Rinse brigade who will, if they have not been already, probably be seen off by his latest bufoonary. This is not to say Boris is unintelligent or well meaning but dear God the country deserves better.
On Newsnight tonight Lord Bilimoria of Chelsea discussed, in relation to staff shortages in hospitality caused by young unvaccinated people isolating, that he himself was isolating essentially unnecessarily for ten days even though he tests himself daily with a LFD and each test is negative. I'm sure he was about to say why not allow the LFD result to act as a Green Light but the interview concluded. Its obvious to all that the Avacta LFD can and should be used in this way but first we need to throw all the Innova tests in the bin, funny thing is I'm sure some American chap suggested just that ....
"They don't agree with the two jab scenario" to be fair only a complete moron would agree with the that scenario. The world knows that folks who have had two jabs can still catch Covid and can still pass it on, the nations newshound Andrew Marr demonstrated that for all to see. What baffles me is why the provarication given that we now have an LFT that is easy to use and highly Sensitive. The answer should be obvious but it is still being debated. Test instead of bl**dy isolate and travel passports based on testing, simples and guess what, I dont get paid anything like the various consulants we see on tv every 5 minutes however, I am available for hire!
Just to say regarding BAMS unfortunately Handys mates had too many PCR tests to sell for the original BAMS concept to be taken up by our Government but, the concept has been proven and it was evident its application in a wide range of diagnostic tests remained in prospect with Adeptrix and Bruker. Yet another significant income stream in prospect.